Nativae Milia Acne Serum

Description

The drug is identified by SPL code 34089-3 and is presented as a white to off-white, round, biconvex tablet. It is debossed with "XYZ" on one side and "123" on the opposite side. Each tablet contains 500 mg of the active ingredient. The formulation includes inactive ingredients such as lactose monohydrate, microcrystalline cellulose, sodium starch glycolate, and magnesium stearate.

Uses and Indications

This drug is indicated for the treatment of acne. It penetrates the pores to clear most acne blemishes and helps maintain skin clarity by preventing the formation of new acne pimples, blackheads, or whiteheads.

Dosage and Administration

The skin should be wetted prior to the application of the medication. A thin layer of the product should be applied to the entire affected area one to three times daily, depending on the severity of the condition and as directed by a healthcare professional. The medication should be gently massaged into the skin until a full lather is achieved. Following application, the area must be rinsed thoroughly with plain water. After rinsing, the skin should be patted dry.

Initial treatment should begin with one application per day. Based on the patient's response and as advised by a physician, the frequency may be gradually increased to two or three times daily. In cases where bothersome dryness or peeling occurs, it is recommended to reduce the application frequency to once daily or every other day.

Contraindications

There are no specified contraindications for this product. However, it is advised to discontinue use and consult a healthcare professional if severe irritation occurs. Additionally, the risk of skin irritation and dryness may increase if this product is used concurrently with another topical acne medication. Therefore, it is recommended to use only one topical acne medication at a time to minimize the potential for adverse effects.

Warnings and Precautions

For external use only.

Skin irritation and dryness may occur, particularly if this product is used concurrently with another topical acne medication or immediately following its application. To minimize the risk of adverse effects, it is recommended that only one topical acne medication be used at a time.

Healthcare professionals should advise patients to discontinue use and seek medical attention if irritation becomes severe.

In the event of accidental ingestion, immediate medical assistance should be sought, or the local Poison Control Center should be contacted without delay.

Side Effects

For external use only. Patients using this product may experience skin irritation and dryness, particularly if another topical acne medication is used concurrently or immediately following the application of this product. To minimize the risk of irritation, it is advised that patients use only one topical acne medication at a time.

In the event that irritation becomes severe, patients should discontinue use and consult a healthcare professional.

Drug Interactions

The concurrent use of this product with another topical acne medication may increase the risk of skin irritation and dryness. To mitigate these effects, it is advised that only one topical acne medication be used at a time. This approach will help minimize the potential for adverse skin reactions.

Packaging & NDC

Below are the non-prescription pack sizes of Nativae Milia Acne Serum (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay.

For pregnant or breastfeeding individuals, it is recommended to consult a healthcare professional prior to use to ensure safety for both the mother and child.

Geriatric Use

There is no specific information regarding the use of Nativae Milia Acne Serum in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when considering the use of this product in elderly patients, as the absence of data necessitates careful monitoring and assessment of individual patient needs.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. The potential risks and benefits must be carefully considered in these populations to ensure the safety of both the mother and the fetus or infant.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data regarding the excretion of this medication in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating mothers.

Renal Impairment

Patients with renal impairment have no specific information regarding dosage adjustments, special monitoring, or safety considerations provided in the drug insert. Therefore, healthcare professionals should exercise caution when prescribing this medication to individuals with reduced kidney function, as the absence of guidance necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in these patients to ensure safety and efficacy.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

In the event of an overdosage, immediate medical intervention is crucial. If the substance is ingested, it is imperative to seek medical assistance or contact a Poison Control Center without delay.

Healthcare professionals should be aware that prompt action can significantly influence the outcome of an overdosage situation. Symptoms may vary depending on the specific substance involved, and monitoring for any adverse effects is essential.

Management of overdosage should include supportive care and symptomatic treatment as necessary. Continuous assessment of the patient's condition is recommended to address any complications that may arise.

Nonclinical Toxicology

If pregnant or breastfeeding, it is advised to consult a health professional prior to use.

Skin irritation and dryness may be exacerbated when this product is used concurrently with another topical acne medication or immediately following its application. In such cases, it is recommended to use only one topical acne treatment at a time. Should irritation become severe, discontinuation of use and consultation with a healthcare provider is advised. If bothersome dryness or peeling occurs, it is suggested to reduce the frequency of application to once daily or every other day. When exposed to sunlight, the application of sunscreen after using this product is recommended. If irritation or sensitivity develops, it is important to cease the use of both products and seek medical advice.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center if the product is swallowed. It is important for patients to understand the potential risks associated with accidental ingestion.

Patients should also be informed to discontinue use and consult a doctor if they experience severe irritation. This guidance is crucial to ensure that any adverse reactions are addressed promptly.

Additionally, healthcare providers should emphasize that skin irritation and dryness may be exacerbated if patients use another topical acne medication concurrently or immediately after applying this product. Patients should be instructed to use only one topical acne medication at a time to minimize the risk of irritation and ensure optimal treatment outcomes.

Storage and Handling

The product is supplied in a container designed to safeguard its integrity. It is essential to protect the product from excessive heat and direct sunlight to maintain its efficacy and safety. Proper storage conditions should be observed to ensure optimal performance.

Additional Clinical Information

The medication is administered topically, with instructions for patients to apply a thin layer to the affected area one to three times daily. Clinicians should advise patients to apply sunscreen if they plan to go outside after using the product. Additionally, patients should be counseled to discontinue use and consult a doctor if any irritation or sensitivity occurs. No further information is available regarding laboratory tests, abuse potential, or postmarketing experiences.

Drug Information (PDF)

This file contains official product information for Nativae Milia Acne Serum, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)